Neurocrine Biosciences Inc. (NBIX) Jumped 5.89% or 5.0 To Price $89.83 On Thursday


Neurocrine Biosciences Inc. (NBIX) jumped 5.89% or 5.0 to $89.83. It is around 1.36 million shares traded, which is 148.96% compare to the average total volume 911824. The market cap of NBIX is $8.16 billion. The year to date change is 26.92%. The 52 week price range is from $64.72 to $126.98. Price of NBIX have changed 2.24% during last week. It have changed 0.60% over last month, 18.20% over last 3 months, -27.72% over last 6 months and -7.52% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 83.94. It is -6.56% below current price. The 200-day Moving Averages for NBIX is 98.58. It is 9.74% above current price. The 52-week High is 126.98. It is 41.36% from the current price. The 52-week Low is 64.72. It is -27.95% from current price.

There are some statistics of NBIX. It is has market cap $8.16 billion. The share outstanding is 90.82 million. The average volume is 911824. The percent of top 15 Institution holding is 170.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is 4.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is 2.33%.


Tags:

Share this post